A policy approach to the development of molecular diagnostic tests.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21057480.
- Also identified by DOI 10.1038/nbt1110-1157.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Efficiently generating evidence of clinical utility is a major challenge for ensuring clinical adoption of valuable diagnostics. A new approach to reimbursement in the United States offers a balance between evidence and incentives for molecular diagnostic tests.
Medical subject headings
- Molecular Diagnostic Techniques
- Policy